{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T06:35:37Z","timestamp":1771655737788,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T00:00:00Z","timestamp":1671235200000},"content-version":"vor","delay-in-days":16,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Health science foundation of Zhejiang Province","award":["2022RC191"],"award-info":[{"award-number":["2022RC191"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82101709"],"award-info":[{"award-number":["82101709"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Proteom"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Recurrent spontaneous abortion (RSA) is a common and complicated pregnancy-related disease that lacks a suitable biomarker to predict its recrudescence.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Tandem mass tag (TMT) analysis was conducted to obtain quantitative proteomic profiles in follicular fluid from patients with a history of RSA and from control group. ELISA validation of candidate differentially expressed proteins was conducted in a larger group of patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 836 proteins were identified by TMT analysis; 51 were upregulated and 47 were downregulated in follicular fluid from cases of RSA versus control group. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes analysis revealed several important pathways were enriched, involving a dysregulated immunoglobulin Fc receptor signaling pathway and overactivated complement cascade pathways. ELISA validated the differential expression of two proteins, histidine-rich globulin (HRG) and complement C4-B (C4B), which were downregulated and upregulated, respectively, in follicular fluid of patients with RSA. We performed receiver operating characteristic curve analysis of the ELISA results with the outcomes of current IVF cycles as classification variables. The area under the curve results for HRG alone, C4B alone and HRG-C4B combined were 0.785, 0.710 and 0.895, respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>TMT analysis identified 98 differentially expressed proteins in follicular fluid from patients with RSA, indicating follicle factors that act as early warning factors for the occurrence of RSA. Among them, HRG and C4B provide candidate markers to predict the clinical outcomes of IVF\/ICSI cycles, and the potential for modeling an early detection system for RSA.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12014-022-09383-9","type":"journal-article","created":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T06:02:42Z","timestamp":1671256962000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Decreased histidine-rich glycoprotein and increased complement C4-B protein levels in follicular fluid predict the IVF outcomes of recurrent spontaneous abortion"],"prefix":"10.1186","volume":"19","author":[{"given":"Xiaohe","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiamin","family":"Jin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yin-Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yerong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomei","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,17]]},"reference":[{"issue":"5","key":"9383_CR1","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1016\/j.fertnstert.2012.06.048","volume":"98","author":"Practice Committee of the American Society for Reproductive M","year":"2012","unstructured":"Practice Committee of the American Society for Reproductive M. Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil Steril. 2012;98(5):1103\u201311.","journal-title":"Fertil Steril"},{"key":"9383_CR2","doi-asserted-by":"publisher","first-page":"331","DOI":"10.2147\/IJWH.S100817","volume":"9","author":"H El Hachem","year":"2017","unstructured":"El Hachem H, Crepaux V, May-Panloup P, Descamps P, Legendre G, Bouet PE. Recurrent pregnancy loss: current perspectives. Int J Women\u2019s Health. 2017;9:331\u201345.","journal-title":"Int J Women's Health"},{"issue":"1","key":"9383_CR3","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41572-020-00228-z","volume":"6","author":"E Dimitriadis","year":"2020","unstructured":"Dimitriadis E, Menkhorst E, Saito S, Kutteh WH, Brosens JJ. Recurrent pregnancy loss. Nat Rev Dis Primers. 2020;6(1):98.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"9383_CR4","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ogc.2014.10.002","volume":"42","author":"L Shahine","year":"2015","unstructured":"Shahine L, Lathi R. Recurrent pregnancy loss: evaluation and treatment. Obstet Gynecol Clin North Am. 2015;42(1):117\u201334.","journal-title":"Obstet Gynecol Clin North Am"},{"key":"9383_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l869","volume":"364","author":"MC Magnus","year":"2019","unstructured":"Magnus MC, Wilcox AJ, Morken NH, Weinberg CR, Haberg SE. Role of maternal age and pregnancy history in risk of miscarriage: prospective register based study. BMJ. 2019;364: l869.","journal-title":"BMJ"},{"issue":"3","key":"9383_CR6","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.3892\/mmr.2017.6890","volume":"16","author":"Y Wu","year":"2017","unstructured":"Wu Y, He J, Guo C, Zhang Y, Yang W, Xin M, Liang X, Yin X, Wang J, Liu Y. Serum biomarker analysis in patients with recurrent spontaneous abortion. Mol Med Rep. 2017;16(3):2367\u201378.","journal-title":"Mol Med Rep"},{"key":"9383_CR7","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12014-019-9256-y","volume":"16","author":"Y Cui","year":"2019","unstructured":"Cui Y, He L, Yang CY, Ye Q. iTRAQ and PRM-based quantitative proteomics in early recurrent spontaneous abortion: biomarkers discovery. Clin Proteomics. 2019;16:36.","journal-title":"Clin Proteomics"},{"issue":"2","key":"9383_CR8","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.fertnstert.2014.11.015","volume":"103","author":"DA Dumesic","year":"2015","unstructured":"Dumesic DA, Meldrum DR, Katz-Jaffe MG, Krisher RL, Schoolcraft WB. Oocyte environment: follicular fluid and cumulus cells are critical for oocyte health. Fertil Steril. 2015;103(2):303\u201316.","journal-title":"Fertil Steril"},{"issue":"5","key":"9383_CR9","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1093\/oxfordjournals.humrep.a136944","volume":"4","author":"PL Nayudu","year":"1989","unstructured":"Nayudu PL, Lopata A, Jones GM, Gook DA, Bourne HM, Sheather SJ, Brown TC, Johnston WI. An analysis of human oocytes and follicles from stimulated cycles: oocyte morphology and associated follicular fluid characteristics. Hum Reprod. 1989;4(5):558\u201367.","journal-title":"Hum Reprod"},{"issue":"11","key":"9383_CR10","doi-asserted-by":"publisher","first-page":"3445","DOI":"10.1002\/pmic.200500775","volume":"6","author":"YS Kim","year":"2006","unstructured":"Kim YS, Kim MS, Lee SH, Choi BC, Lim JM, Cha KY, Baek KH. Proteomic analysis of recurrent spontaneous abortion: Identification of an inadequately expressed set of proteins in human follicular fluid. Proteomics. 2006;6(11):3445\u201354.","journal-title":"Proteomics"},{"issue":"17","key":"9383_CR11","doi-asserted-by":"publisher","first-page":"7469","DOI":"10.1021\/ac301572t","volume":"84","author":"GC McAlister","year":"2012","unstructured":"McAlister GC, Huttlin EL, Haas W, Ting L, Jedrychowski MP, Rogers JC, Kuhn K, Pike I, Grothe RA, Blethrow JD, et al. Increasing the multiplexing capacity of TMTs using reporter ion isotopologues with isobaric masses. Anal Chem. 2012;84(17):7469\u201378.","journal-title":"Anal Chem"},{"issue":"6","key":"9383_CR12","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1021\/jasms.0c00464","volume":"32","author":"D Yu","year":"2021","unstructured":"Yu D, Wang Z, Cupp-Sutton KA, Guo Y, Kou Q, Smith K, Liu X, Wu S. Quantitative top-down proteomics in complex samples using protein-level tandem mass tag labeling. J Am Soc Mass Spectrom. 2021;32(6):1336\u201344.","journal-title":"J Am Soc Mass Spectrom"},{"issue":"5","key":"9383_CR13","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S0143-4004(05)80415-1","volume":"15","author":"F Saji","year":"1994","unstructured":"Saji F, Koyama M, Matsuzaki N. Current topic: human placental Fc receptors. Placenta. 1994;15(5):453\u201366.","journal-title":"Placenta"},{"issue":"7","key":"9383_CR14","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.placenta.2012.03.010","volume":"33","author":"R Kawaguchi","year":"2012","unstructured":"Kawaguchi R, Nunomura S, Umehara N, Nikaido T, Huppertz B, Tanaka T, Ra C. Multiple injections of anti-mouse beta2glycoprotein 1 antibody induce FcRgamma-dependent fetal growth restriction (FGR) in mice. Placenta. 2012;33(7):540\u20137.","journal-title":"Placenta"},{"issue":"5","key":"9383_CR15","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1080\/08820130802191615","volume":"37","author":"G Girardi","year":"2008","unstructured":"Girardi G. Complement inhibition keeps mothers calm and avoids fetal rejection. Immunol Invest. 2008;37(5):645\u201359.","journal-title":"Immunol Invest"},{"issue":"1","key":"9383_CR16","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00281-017-0645-x","volume":"40","author":"G Girardi","year":"2018","unstructured":"Girardi G. Complement activation, a threat to pregnancy. Semin Immunopathol. 2018;40(1):103\u201311.","journal-title":"Semin Immunopathol"},{"issue":"1","key":"9383_CR17","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.molimm.2015.02.030","volume":"67","author":"JF Regal","year":"2015","unstructured":"Regal JF, Gilbert JS, Burwick RM. The complement system and adverse pregnancy outcomes. Mol Immunol. 2015;67(1):56\u201370.","journal-title":"Mol Immunol"},{"issue":"2","key":"9383_CR18","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1159\/000292384","volume":"39","author":"JR Tichenor","year":"1995","unstructured":"Tichenor JR, Bledsoe LB, Opsahl MS, Cunningham DS. Activation of complement in humans with a first-trimester pregnancy loss. Gynecol Obstet Invest. 1995;39(2):79\u201382.","journal-title":"Gynecol Obstet Invest"},{"issue":"12","key":"9383_CR19","doi-asserted-by":"publisher","first-page":"5602","DOI":"10.4049\/jimmunol.1501361","volume":"195","author":"M Petitbarat","year":"2015","unstructured":"Petitbarat M, Durigutto P, Macor P, Bulla R, Palmioli A, Bernardi A, De Simoni MG, Ledee N, Chaouat G, Tedesco F. Critical role and therapeutic control of the lectin pathway of complement activation in an abortion-prone mouse mating. J Immunol. 2015;195(12):5602\u20137.","journal-title":"J Immunol"},{"key":"9383_CR20","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1034\/j.1600-065X.2000.17801.x","volume":"178","author":"BZ Schmidt","year":"2000","unstructured":"Schmidt BZ, Colten HR. Complement: a critical test of its biological importance. Immunol Rev. 2000;178:166\u201376.","journal-title":"Immunol Rev"},{"issue":"10","key":"9383_CR21","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1093\/humrep\/del229","volume":"21","author":"M Sugiura-Ogasawara","year":"2006","unstructured":"Sugiura-Ogasawara M, Nozawa K, Nakanishi T, Hattori Y, Ozaki Y. Complement as a predictor of further miscarriage in couples with recurrent miscarriages. Hum Reprod. 2006;21(10):2711\u20134.","journal-title":"Hum Reprod"},{"issue":"8","key":"9383_CR22","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1002\/j.1460-2075.1984.tb02052.x","volume":"3","author":"SK Law","year":"1984","unstructured":"Law SK, Dodds AW, Porter RR. A comparison of the properties of two classes, C4A and C4B, of the human complement component C4. EMBO J. 1984;3(8):1819\u201323.","journal-title":"EMBO J"},{"issue":"7","key":"9383_CR23","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1182\/blood-2010-09-303842","volume":"117","author":"IK Poon","year":"2011","unstructured":"Poon IK, Patel KK, Davis DS, Parish CR, Hulett MD. Histidine-rich glycoprotein: the Swiss Army knife of mammalian plasma. Blood. 2011;117(7):2093\u2013101.","journal-title":"Blood"},{"issue":"2","key":"9383_CR24","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1055\/s-0038-1661073","volume":"51","author":"HR Lijnen","year":"1984","unstructured":"Lijnen HR, Van Hoef B, Collen D. Histidine-rich glycoprotein modulates the anticoagulant activity of heparin in human plasma. Thromb Haemost. 1984;51(2):266\u20138.","journal-title":"Thromb Haemost"},{"issue":"5","key":"9383_CR25","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1111\/j.1538-7836.2005.01238.x","volume":"3","author":"N Tsuchida-Straeten","year":"2005","unstructured":"Tsuchida-Straeten N, Ensslen S, Schafer C, Woltje M, Denecke B, Moser M, Graber S, Wakabayashi S, Koide T, Jahnen-Dechent W. Enhanced blood coagulation and fibrinolysis in mice lacking histidine-rich glycoprotein (HRG). J Thromb Haemost JTH. 2005;3(5):865\u201372.","journal-title":"J Thromb Haemost JTH"},{"issue":"1","key":"9383_CR26","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1172\/JCI9061","volume":"107","author":"R Simantov","year":"2001","unstructured":"Simantov R, Febbraio M, Crombie R, Asch AS, Nachman RL, Silverstein RL. Histidine-rich glycoprotein inhibits the antiangiogenic effect of thrombospondin-1. J Clin Investig. 2001;107(1):45\u201352.","journal-title":"J Clin Investig"},{"issue":"2","key":"9383_CR27","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1158\/0008-5472.CAN-03-1941","volume":"64","author":"AK Olsson","year":"2004","unstructured":"Olsson AK, Larsson H, Dixelius J, Johansson I, Lee C, Oellig C, Bjork I, Claesson-Welsh L. A fragment of histidine-rich glycoprotein is a potent inhibitor of tumor vascularization. Can Res. 2004;64(2):599\u2013605.","journal-title":"Can Res"},{"issue":"1","key":"9383_CR28","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ccr.2010.11.009","volume":"19","author":"C Rolny","year":"2011","unstructured":"Rolny C, Mazzone M, Tugues S, Laoui D, Johansson I, Coulon C, Squadrito ML, Segura I, Li X, Knevels E, et al. HRG inhibits tumor growth and metastasis by inducing macrophage polarization and vessel normalization through downregulation of PlGF. Cancer Cell. 2011;19(1):31\u201344.","journal-title":"Cancer Cell"},{"issue":"16","key":"9383_CR29","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1016\/j.molimm.2009.07.011","volume":"46","author":"GA Manderson","year":"2009","unstructured":"Manderson GA, Martin M, Onnerfjord P, Saxne T, Schmidtchen A, Mollnes TE, Heinegard D, Blom AM. Interactions of histidine-rich glycoprotein with immunoglobulins and proteins of the complement system. Mol Immunol. 2009;46(16):3388\u201398.","journal-title":"Mol Immunol"},{"issue":"10","key":"9383_CR30","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1177\/1933719110374366","volume":"17","author":"S Nordqvist","year":"2010","unstructured":"Nordqvist S, Karehed K, Hambiliki F, Wanggren K, Stavreus-Evers A, Akerud H. The presence of histidine-rich glycoprotein in the female reproductive tract and in embryos. Reprod Sci. 2010;17(10):941\u20137.","journal-title":"Reprod Sci"},{"key":"9383_CR31","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1477-7827-12-70","volume":"12","author":"E Elenis","year":"2014","unstructured":"Elenis E, Lindgren KE, Karypidis H, Skalkidou A, Hosseini F, Bremme K, Landgren BM, Skjoldebrand-Sparre L, Stavreus-Evers A, Sundstrom-Poromaa I, et al. The histidine-rich glycoprotein A1042G polymorphism and recurrent miscarriage: a pilot study. Reprod Biol Endocrinol RB&E. 2014;12:70.","journal-title":"Reprod Biol Endocrinol RB&E"},{"issue":"8","key":"9383_CR32","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1111\/aogs.12155","volume":"92","author":"KE Lindgren","year":"2013","unstructured":"Lindgren KE, Karehed K, Karypidis H, Hosseini F, Bremme K, Landgren BM, Skjoldebrand-Sparre L, Stavreus-Evers A, Sundstrom-Poromaa I, Akerud H. Histidine-rich glycoprotein gene polymorphism in patients with recurrent miscarriage. Acta Obstet Gynecol Scand. 2013;92(8):974\u20137.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"22","key":"9383_CR33","doi-asserted-by":"publisher","first-page":"6653","DOI":"10.1021\/bi962573n","volume":"36","author":"NN Gorgani","year":"1997","unstructured":"Gorgani NN, Parish CR, Easterbrook Smith SB, Altin JG. Histidine-rich glycoprotein binds to human IgG and C1q and inhibits the formation of insoluble immune complexes. Biochemistry. 1997;36(22):6653\u201362.","journal-title":"Biochemistry"},{"issue":"2","key":"9383_CR34","first-page":"296","volume":"81","author":"NS Chang","year":"1994","unstructured":"Chang NS, Leu RW, Anderson JK, Mole JE. Role of N-terminal domain of histidine-rich glycoprotein in modulation of macrophage Fc gamma receptor-mediated phagocytosis. Immunology. 1994;81(2):296\u2013302.","journal-title":"Immunology"},{"issue":"4","key":"9383_CR35","first-page":"532","volume":"77","author":"NS Chang","year":"1992","unstructured":"Chang NS, Leu RW, Rummage JA, Anderson JK, Mole JE. Regulation of macrophage Fc receptor expression and phagocytosis by histidine-rich glycoprotein. Immunology. 1992;77(4):532\u20138.","journal-title":"Immunology"},{"issue":"3","key":"9383_CR36","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837\u201345.","journal-title":"Biometrics"},{"issue":"8","key":"9383_CR37","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1111\/eci.12478","volume":"45","author":"JM Twigt","year":"2015","unstructured":"Twigt JM, Bezstarosti K, Demmers J, Lindemans J, Laven JS, Steegers-Theunissen RP. Preconception folic acid use influences the follicle fluid proteome. Eur J Clin Invest. 2015;45(8):833\u201341.","journal-title":"Eur J Clin Invest"}],"container-title":["Clinical Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12014-022-09383-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12014-022-09383-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12014-022-09383-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T06:02:54Z","timestamp":1671256974000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalproteomicsjournal.biomedcentral.com\/articles\/10.1186\/s12014-022-09383-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["9383"],"URL":"https:\/\/doi.org\/10.1186\/s12014-022-09383-9","relation":{},"ISSN":["1542-6416","1559-0275"],"issn-type":[{"value":"1542-6416","type":"print"},{"value":"1559-0275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"16 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Sir Run Run Shaw Hospital Research and Ethics Committee (approval number: 20200821-31). All patients provided written informed consent before enrollment, and obtained materials and questionnaires were processed anonymously.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors report no conflicts of interest in this work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"47"}}